Laboratory research only. Never for use in people or animals. Qualified research customers only.
Select current lots report over 99% purity Exact results vary by material and lot. View lab records →
f
f
Form BPC-157 / TB-500 research material vial
Form / material film360° studio loop
Hyperreal material study08.1 sec / seamless
Recovery & Healing Available for research

Lot-documented reference material

BPC-157 / TB-500 10 mg

A precisely documented two-component peptide blend, prepared for controlled laboratory study and analytical comparison.

99.64% Average reported purityCurrent lot HVY-ACE26-BPC/TB-10/10 · HPLC/UV + mass spectrometry View lot report →
$65 CoA available
One-time research orderNo subscription
1
See lab records

Free U.S. shipping · Freeze-dried · CoA available

Independent lot recordLot HVY-ACE26-BPC/TB-10/10 · 99.64% purity · HPLC/UV & mass spectrometryOpen lot report →
Lab-reported identityHPLC/UV & mass spectrometry
Lot matchedCoA available
Freeze-driedReference material
Research onlyQualified buyers
01Material details

Review the identity, current reported result, methods, storage note, and document status in the material table below.

02Independent record

Open the independent report above to verify the values published on this page before placing a research order.

03Research-use requirements

For laboratory research only. Never for use in people or animals. Obtain and review the supplier-issued SDS before handling or storage.

04Potential human benefits
  • Tendon + ligament recovery potentialPreclinical BPC-157 research has reported changes in fibroblast activity, collagen organization, and blood-vessel signaling in poorly vascularized tissues such as tendons and ligaments.
  • Muscle + wound repair pathwaysThymosin-beta-4-related signaling can support cell migration and actin remodeling, while both components are studied for angiogenesis and tissue-repair responses.
  • Gut-lining resilienceBPC-157 originated from gastric-protein research and has shown mucosal-protection and repair signals in animal models, creating interest in intestinal barrier and ulcer research.

See what human studies have shown and what remains unknown.

The Form standard

Built to be examined,
not assumed.

Every listing keeps the material, current record, and research boundary in one clear review path.

01Lot-linked record

The available report is connected directly to the listing.

02Methods shown

Review the stated analytical methods before ordering.

03Freeze-dried format

Presented as a laboratory reference material.

04Clear limits

Research only. Never for use in people or animals.

Potential human relevance

A repair-focused combination
with wide preclinical appeal.

BPC-157 and thymosin-related pathways converge on cell migration, angiogenesis, collagen organization, and matrix remodeling. That creates compelling hypotheses for tendon, muscle, wound, and gut repair—but controlled human efficacy evidence is still minimal.

01

Tendon + ligament recovery potential

Preclinical BPC-157 research has reported changes in fibroblast activity, collagen organization, and blood-vessel signaling in poorly vascularized tissues such as tendons and ligaments.

02

Muscle + wound repair pathways

Thymosin-beta-4-related signaling can support cell migration and actin remodeling, while both components are studied for angiogenesis and tissue-repair responses.

03

Gut-lining resilience

BPC-157 originated from gastric-protein research and has shown mucosal-protection and repair signals in animal models, creating interest in intestinal barrier and ulcer research.

How the potential connects to the biology

01 / Mechanism

Why it may matter

Cell-migration, extracellular-matrix turnover, angiogenesis, and injury-model signaling.

02 / Research markers

What studies track

Migration assays, tube formation, ERK-linked signaling, collagen deposition, and model-specific inflammatory markers.

03 / Evidence level

How strong is the evidence?

Predominantly cell and animal evidence. Human BPC-157 data are limited to very small pilot and retrospective reports; the combination has not been clinically validated.

What remains unknown: Human efficacy has not been established for healing tendons, muscle, wounds, or the gut. The cited BPC-157 safety pilot included only two people, and no trial validates this combination.

Primary research: BPC-157 in cell and animal repair models Human pilot: IV BPC-157 tolerability Primary research: thymosin beta-4 repair biology

Material details

The essentials.

A two-component peptide blend with component identities and lot results shown below.

BPC-157CAS 137525-51-0; C62H98N16O22; approximately 1419.5 g/mol
Thymosin beta-4CAS 77591-33-4; C212H350N56O78S; approximately 4963 g/mol
Lot result99.64% average purity; white lyophilized powder
Tested byFreedom Diagnostics; lot HVY-ACE26-BPC/TB-10/10; HPLC/UV and mass spectrometry
StorageNot stated on the current lot CoA. Obtain and follow the supplier-issued SDS before handling or storage.
Lab recordsCurrent lot CoA (PDF) · Request supplier-issued SDS

SDS status: not currently posted. Request and review the supplier SDS before handling or storage; this page and CoA do not replace it.

Made for research

For in-vitro lab research, method development, and identity testing by qualified research customers.

Proof by lot

The available CoA is tied to this material and lot. Open it above or visit the CoA library.

Clear limits

For laboratory research only. Never for use in people or animals.

Before you order

By ordering, you confirm qualified research-only use.